Applications of machine learning for speech-based biomarkers in early Alzheimer’s disease and mild cognitive impairment: a narrative review
Can AI hear Alzheimer’s disease before you can?
Read more

Can AI hear Alzheimer’s disease before you can?
Read more
By the time Parkinson’s disease is formally diagnosed, up to 60% of the brain’s dopamine producing neurons…
Read more
Speech loss is one of the most devastating outcomes for people living with ALS. Yet active…
Read more
Struggling to follow a conversation in noise could be more than just annoying, it might signal…
Read more
A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for…
Read more
Could a 10-second speech test repeating “pa,” “ta,” “ka” be the key to earlier detection of…
Read more
For more information
If you are interested in seeing how Redenlab can help your organisation, please fill in the form and we’ll get in contact with you.
